Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
Guirguis, Hany R
Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature. [electronic resource] - British journal of haematology Oct 2012 - 39-49 p. digital
Publication Type: Journal Article; Review
1365-2141
10.1111/j.1365-2141.2012.09247.x doi
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Central Nervous System Neoplasms--drug therapy
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Female
Humans
Incidence
Lymphoma, Large B-Cell, Diffuse--drug therapy
Male
Methotrexate--administration & dosage
Middle Aged
Prednisone--administration & dosage
Recurrence
Retrospective Studies
Risk Factors
Rituximab
Vincristine--administration & dosage
Young Adult
Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature. [electronic resource] - British journal of haematology Oct 2012 - 39-49 p. digital
Publication Type: Journal Article; Review
1365-2141
10.1111/j.1365-2141.2012.09247.x doi
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Central Nervous System Neoplasms--drug therapy
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Female
Humans
Incidence
Lymphoma, Large B-Cell, Diffuse--drug therapy
Male
Methotrexate--administration & dosage
Middle Aged
Prednisone--administration & dosage
Recurrence
Retrospective Studies
Risk Factors
Rituximab
Vincristine--administration & dosage
Young Adult